The Royal Wolverhampton NHS Trust
Wolverhampton, West Midlands, WV10 0QP, United Kingdom
NCT Number: NCT04326673
The purpose is to evaluate Sal-T against standard biomarkers of male gonadal status based on serum T, calculated free T and BAT. The optimal salivary sampling in terms of fasting and time of day will also be defined.
The ultimate aim is to add Sal-T into the Trust's repertoire of tests in investigating suspected hypogonadism in men.
Looking for future studies?
Notify Me20 year–60 year
Male
Observational
Wolverhampton, West Midlands, WV10 0QP, United Kingdom
To investigate whether salivary (free) testosterone is subject to similar prandial variations reported for serum total testosterone.
Study 1:
Assessment of diurnal variation in salivary testosterone adjusted for prandial state in 20 healthy men.
Study 2:
Measurement of salivary and serum testosterone and related biomarkers before and after a standard 75g oral glucose load in 40 men.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
For 1st part of study -volunteers:
Inclusion criteria
Exclusion criteria
2nd part of study for glucose load - oral glucose tolerance test (OGTT):
Inclusion criteria
Exclusion criteria
salivary testosterone measurements taken in morning and evening and a single blood test for testosterone taken
salivary tstosterone and blood testosterone measurements
Time frame: 24 hours
testosterone levels
Time frame: 2 hours
testosterone levels
The Royal Wolverhampton Hospitals NHS Trust
Other Gov
Acronym: SalT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05381831
Endocrine System Diseases, Eunuchism
Gainesville, Florida, United States
View Trial DetailsNCT04456296
Endocrine System Diseases, Eunuchism
Birmingham, Alabama, United States
View Trial DetailsNCT03254641
Endocrine System Diseases, Eunuchism
Copenhagen, Denmark
View Trial DetailsNCT04558567
Endocrine System Diseases, Eunuchism
Birmingham, Alabama, United States
View Trial Details